218 Likes Disposal of own shares Brussels (Belgium), 19 August 2022 ¨C 20:00 (CEST) ¨C Regulated information In accordance with article 8:6 of the Royal Decree executing the Belgian Code of Companies and Associations, ½ðºÌÓéÀÖ³Ç announces that, following exercises of stock options by members of its personnel, it has disposed of ½ðºÌÓéÀÖ³Ç shares OTC in view of deliveries of these shares to the relevant members of the personnel, within the framework of the Long-Term Incentive Program of the ½ðºÌÓéÀÖ³Ç Group, as follows: This press release is available on ½ðºÌÓéÀÖ³Ç SA/NV¡¯s website via the following link. For further information, contact ½ðºÌÓéÀÖ³Ç: Investor Relations Antje Witte T +32 2 559 94 14 antje.witte@ucb.com Corporate Communications Laurent Schots T +32 2 559 92 64 laurent.schots@ucb.com About ½ðºÌÓéÀÖ³Ç ½ðºÌÓéÀÖ³Ç, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 8 600 people in nearly 40 countries, the company generated revenue of € 5.8 billion in 2021. ½ðºÌÓéÀÖ³Ç is listed on Euronext Brussels (symbol: ½ðºÌÓéÀÖ³Ç). Follow us on Twitter: @½ðºÌÓéÀÖ³Ç_news Asset Download 220819 - Disposals of own shares ENG 220819 - Alie nation d actions propres FR 220819 - Vervreemding van eigen aandelen NL 218 Likes
